Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adaptor Proteins, Vesicular Transport | 11 | 2017 | 34 | 4.040 |
Why?
|
| Endothelial Cells | 14 | 2020 | 57 | 2.790 |
Why?
|
| Pulmonary Artery | 4 | 2022 | 43 | 2.040 |
Why?
|
| Lung | 11 | 2017 | 159 | 1.810 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 16 | 1.660 |
Why?
|
| Caveolae | 7 | 2015 | 17 | 1.400 |
Why?
|
| Endocytosis | 7 | 2015 | 17 | 1.390 |
Why?
|
| Capillary Permeability | 5 | 2013 | 28 | 0.910 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2023 | 30 | 0.860 |
Why?
|
| Mice | 14 | 2020 | 1345 | 0.860 |
Why?
|
| Cell Proliferation | 4 | 2020 | 167 | 0.830 |
Why?
|
| Animals | 18 | 2020 | 3510 | 0.820 |
Why?
|
| RNA, Small Interfering | 6 | 2017 | 72 | 0.790 |
Why?
|
| RNA, Long Noncoding | 1 | 2022 | 4 | 0.790 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2016 | 13 | 0.730 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 584 | 0.610 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2015 | 16 | 0.600 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2015 | 22 | 0.600 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 31 | 0.590 |
Why?
|
| ets-Domain Protein Elk-1 | 2 | 2017 | 4 | 0.580 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 33 | 0.570 |
Why?
|
| Vascular Remodeling | 1 | 2017 | 4 | 0.550 |
Why?
|
| Cell Membrane | 3 | 2011 | 85 | 0.550 |
Why?
|
| SOS1 Protein | 1 | 2016 | 4 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2016 | 12 | 0.540 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 56 | 0.530 |
Why?
|
| Endothelium, Vascular | 6 | 2015 | 47 | 0.500 |
Why?
|
| Smad2 Protein | 1 | 2015 | 2 | 0.490 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 5 | 0.490 |
Why?
|
| Apoptosis | 3 | 2015 | 177 | 0.470 |
Why?
|
| Liposomes | 1 | 2013 | 13 | 0.430 |
Why?
|
| Cells, Cultured | 6 | 2020 | 495 | 0.400 |
Why?
|
| Humans | 18 | 2023 | 25692 | 0.400 |
Why?
|
| Dynamin II | 1 | 2011 | 2 | 0.390 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 509 | 0.380 |
Why?
|
| Down-Regulation | 1 | 2011 | 94 | 0.360 |
Why?
|
| Sex Characteristics | 2 | 2022 | 94 | 0.350 |
Why?
|
| Actins | 2 | 2009 | 29 | 0.350 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 35 | 0.330 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2009 | 7 | 0.330 |
Why?
|
| Qb-SNARE Proteins | 2 | 2005 | 4 | 0.310 |
Why?
|
| Qc-SNARE Proteins | 2 | 2005 | 4 | 0.310 |
Why?
|
| Microscopy, Electron | 5 | 2013 | 61 | 0.300 |
Why?
|
| Rats | 4 | 2019 | 649 | 0.300 |
Why?
|
| Exocytosis | 1 | 2007 | 4 | 0.290 |
Why?
|
| Mitochondria | 1 | 2007 | 62 | 0.280 |
Why?
|
| Qa-SNARE Proteins | 1 | 2005 | 7 | 0.250 |
Why?
|
| Membrane Fusion | 1 | 2005 | 29 | 0.250 |
Why?
|
| Cholesterol | 1 | 2005 | 59 | 0.240 |
Why?
|
| Cell Line | 3 | 2015 | 268 | 0.240 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 6 | 0.220 |
Why?
|
| Carrier Proteins | 1 | 2003 | 96 | 0.210 |
Why?
|
| Mice, Knockout | 4 | 2019 | 284 | 0.210 |
Why?
|
| Sex Chromosomes | 1 | 2022 | 4 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 56 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 3 | 2007 | 71 | 0.190 |
Why?
|
| RNA, Messenger | 2 | 2013 | 284 | 0.190 |
Why?
|
| Neuropeptides | 2 | 2013 | 24 | 0.190 |
Why?
|
| Signal Transduction | 3 | 2015 | 410 | 0.180 |
Why?
|
| Indoles | 2 | 2019 | 35 | 0.180 |
Why?
|
| Pyrroles | 1 | 2019 | 19 | 0.160 |
Why?
|
| Hypoxia | 1 | 2019 | 35 | 0.160 |
Why?
|
| Biotin | 2 | 2011 | 7 | 0.160 |
Why?
|
| Male | 6 | 2020 | 13917 | 0.150 |
Why?
|
| Intercellular Junctions | 2 | 2008 | 9 | 0.140 |
Why?
|
| Systole | 1 | 2017 | 14 | 0.140 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 12 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 14 | 0.140 |
Why?
|
| Hypertrophy | 1 | 2017 | 23 | 0.140 |
Why?
|
| Time-Lapse Imaging | 1 | 2016 | 5 | 0.140 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 12 | 0.140 |
Why?
|
| A549 Cells | 1 | 2016 | 8 | 0.140 |
Why?
|
| Collagen | 1 | 2017 | 80 | 0.140 |
Why?
|
| Ubiquitination | 1 | 2016 | 15 | 0.140 |
Why?
|
| Lipids | 1 | 2017 | 50 | 0.130 |
Why?
|
| Disease Progression | 1 | 2019 | 664 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 91 | 0.130 |
Why?
|
| Cell Movement | 1 | 2016 | 70 | 0.130 |
Why?
|
| Lung Injury | 2 | 2013 | 8 | 0.130 |
Why?
|
| Heart Ventricles | 1 | 2017 | 96 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 92 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 221 | 0.130 |
Why?
|
| Female | 3 | 2022 | 14273 | 0.130 |
Why?
|
| Caveolin 1 | 2 | 2005 | 10 | 0.130 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 2 | 0.130 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Cell Survival | 1 | 2015 | 110 | 0.120 |
Why?
|
| Smoking | 1 | 2015 | 165 | 0.110 |
Why?
|
| Granzymes | 1 | 2013 | 5 | 0.110 |
Why?
|
| Proteolysis | 1 | 2013 | 6 | 0.110 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cations | 1 | 2013 | 15 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 8 | 0.110 |
Why?
|
| Endothelium | 1 | 2013 | 12 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2013 | 23 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2013 | 36 | 0.110 |
Why?
|
| Transfection | 1 | 2013 | 112 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2011 | 66 | 0.110 |
Why?
|
| Models, Animal | 1 | 2013 | 110 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 217 | 0.100 |
Why?
|
| src Homology Domains | 1 | 2011 | 2 | 0.100 |
Why?
|
| Clathrin | 1 | 2011 | 4 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 6 | 0.100 |
Why?
|
| Phenotype | 1 | 2013 | 292 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 4 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2011 | 20 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 111 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2011 | 140 | 0.090 |
Why?
|
| Skull | 1 | 2011 | 22 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 108 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 49 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2011 | 55 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2008 | 24 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2011 | 127 | 0.090 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2009 | 2 | 0.080 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2009 | 2 | 0.080 |
Why?
|
| Pseudopodia | 1 | 2009 | 5 | 0.080 |
Why?
|
| Inflammation | 1 | 2011 | 261 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2009 | 108 | 0.080 |
Why?
|
| Platelet Activating Factor | 1 | 2008 | 6 | 0.080 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2008 | 4 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 6 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2005 | 75 | 0.080 |
Why?
|
| Biological Transport | 1 | 2007 | 38 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 11 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 14 | 0.070 |
Why?
|
| Base Sequence | 1 | 2007 | 90 | 0.070 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2007 | 2 | 0.070 |
Why?
|
| Monocytes | 1 | 2007 | 53 | 0.070 |
Why?
|
| Albumins | 2 | 2005 | 18 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 405 | 0.070 |
Why?
|
| Cell-Free System | 1 | 2005 | 2 | 0.060 |
Why?
|
| Streptavidin | 1 | 2005 | 3 | 0.060 |
Why?
|
| SNARE Proteins | 1 | 2005 | 11 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 41 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 3 | 0.060 |
Why?
|
| Dynamins | 1 | 2003 | 4 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2003 | 8 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 24 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 89 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2003 | 79 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 322 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2011 | 24 | 0.040 |
Why?
|
| Brain | 1 | 2007 | 1560 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2005 | 6 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 21 | 0.030 |
Why?
|
| Integrases | 1 | 2013 | 3 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2013 | 4 | 0.030 |
Why?
|
| Body Fluids | 1 | 2013 | 13 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2013 | 37 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2011 | 17 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 24 | 0.020 |
Why?
|
| Calcium Phosphates | 1 | 2011 | 24 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 45 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 116 | 0.020 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2008 | 3 | 0.020 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2008 | 7 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 29 | 0.020 |
Why?
|
| Cadherins | 1 | 2008 | 28 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 48 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 134 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2008 | 151 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 7 | 0.020 |
Why?
|
| Retroviridae | 1 | 2007 | 5 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 19 | 0.020 |
Why?
|
| Lysophosphatidylcholines | 1 | 2007 | 7 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 133 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 8 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2005 | 14 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2005 | 14 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2005 | 18 | 0.020 |
Why?
|
| Mutation | 1 | 2007 | 325 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 262 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 118 | 0.020 |
Why?
|
| Gold Colloid | 1 | 2002 | 2 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2002 | 12 | 0.010 |
Why?
|
| Nitrates | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 15 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 25 | 0.010 |
Why?
|
| Perfusion | 1 | 2002 | 12 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 65 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 98 | 0.010 |
Why?
|
| Myocardium | 1 | 2002 | 95 | 0.010 |
Why?
|